Search Results 1071-1080 of 13712 for Assay
... assays); Documented progressive disease according to RECIST v1.1 following receipt of at least 2 cycles of one platinum-containing chemotherapy regimen ...
Planned use of other commercially available or investigational cfDNA or gene expression profile assays for rejection surveillance. Pregnant. Hemodynamically ...
Circulating cell-free DNA (cfDNA) from the plasma will be extracted and sequenced to identify somatic mutations that were exposed to the T-cells. Participation ...
GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...
TNBC is defined as negative immunohistochemistry (IHC) assays for Estrogen Receptor (ER), and Progesterone Receptor (PR), and HER2 negative (IHC 0 or 1+, or 2+ ...
... assays for the detection of urothelial carcinoma in urine. J Urol. 2002 May; 167 (5):2001-6. View PubMed; Gostout BS, Strome SE, Clayton AC, McGovern RM ...
The purpose of this study is to collect blood and tissue samples from patients with and without cancer to evaluate laboratory tests for early cancer detection ...
The purpose of this study is to evaluate M7824 monotherapy in participants with advanced or metastatic biliary tract cancer (BTC) who failed or were intolerant ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.